Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics
Lung Cancer: Targets and Therapy · 2025-12 · Volume 16 · 167-198
DOI: 10.2147/lctt.s539777 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lung Cancer: Targets and Therapy, 2025-12. Verfasst von Eman Elayeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, 11942, Jordan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, 11942, Jordan.
- Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.
- Department of Neurology, University of California, Davis, Sacramento, CA, 95817, USA.
- Department of Neurological Surgery, University of California, Davis, Sacramento, CA, 95817, USA.
- Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, 95817, USA.
- Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
ORCID-Profile: Eman Elayeh, Orwa Aboud, Mohammad H Semreen
Zitieren
APA
Elayeh, E., Aleidi, S. M., Aboud, O., Semreen, M. H., Bustanji, Y. K., & Dahabiyeh, L. A. (2025). Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics. Lung Cancer: Targets and Therapy, Volume 16, 167-198. https://doi.org/10.2147/lctt.s539777
Vancouver
Elayeh E, Aleidi SM, Aboud O, Semreen MH, Bustanji YK, Dahabiyeh LA. Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics. Lung Cancer: Targets and Therapy. 2025;Volume 16:167-198. doi:10.2147/lctt.s539777
BibTeX
@article{Elayeh2025,
author = {Elayeh, Eman and Aleidi, Shereen M and Aboud, Orwa and Semreen, Mohammad H and Bustanji, Yasser K and Dahabiyeh, Lina A},
title = {Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics},
journal = {Lung Cancer: Targets and Therapy},
year = {2025},
volume = {Volume 16},
pages = {167--198},
doi = {10.2147/lctt.s539777}
}
EUVIMED